BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report report published on Sunday. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Price Performance

Shares of BIOLASE stock opened at $0.01 on Friday. The stock has a market capitalization of $330,729.30, a price-to-earnings ratio of 0.00 and a beta of 0.67. The business has a 50-day moving average of $0.01 and a 200 day moving average of $0.02. BIOLASE has a 12 month low of $0.02 and a 12 month high of $1.94.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.